Further laboratory investigations revealed IgG autoimmunity towards myelin nodal proteins, neurofascin-186 (NF186), gliomedin, contactin and NCAM in 43% of GBS (n = 100) and 30% of CIDP (n = 50) patients (94). The gene discussed is GLDN; the disease is Guillain-Barre syndrome.